Aerie Pharmaceuticals Inc. | Key People and Executives
Vicente J. Anido
Chairman & Chief Executive Officer
Michael M. du Toit
Independent Director
Julie Harris McHugh
Independent Director
Richard J. Croarkin
Independent Director
Benjamin F. McGraw
Lead Independent Director
Gerald D. Cagle
Independent Director
Murray A. Goldberg
Independent Director
Vicente J. Anido
Chairman & Chief Executive Officer
Thomas A. Mitro
President & Chief Operating Officer
Richard J. Rubino
Chief Financial Officer, Secretary & Treasurer
Richard Lewis
Chief Medical Officer
Casey C. Kopczynski
Chief Scientific Officer
Robert Finan
Finance Director
Jeffrey White
Director-Toxicology & Pharmacokinetics
Gerry McKenzie
Vice President-Commercial Operations
John Maltman
Vice President-Medical Affairs
Tori Arens
Vice President-Drug Product Manufacturing
Eric Carlson
Vice President-Research & Development
Gary Menichini
Vice President-Commercial
Judith J. Robertson
Chief Commercial Officer
Carmen McCormick
Chief Compliance Officer & Corporate Counsel
Theresa Heah
Vice President-Clinical Research & Medical Affairs
Craig R. Skenes
Vice President-Business Development
Michael McCleerey
Vice President-Portfolio Development
Randall Brown
Director-Payer Marketing
Deanne F. Melloy
Vice President-Marketing
Tad Heitmann
Media Contact
Kathleen McGinley
VP-Human Resources & Corporate Services
John LaRocca
General Counsel
Marvin J. Garrett
VP-Regulatory Affairs & Quality Assurance
Michael M. du Toit
Independent Director
Julie Harris McHugh
Independent Director
Richard J. Croarkin
Independent Director
Benjamin F. McGraw
Lead Independent Director
Gerald D. Cagle
Independent Director
Murray A. Goldberg
Independent Director
| Address |
4301 Emperor Boulevard
Durham North Carolina 27703
United States
|
|
Employees
|
- |
| Website |
http://www.aeriepharma.com |
| Updated |
07/08/2019 |
| Aerie Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and diseases of the eye. Its products include Rhopressa and Roclatan. The company was founded by David L. |
